On the expression of fractalkine by rosiglitazone in human renal mesangial cells induced by advanced glycation end products / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 660-661, 2008.
Article
em Zh
| WPRIM
| ID: wpr-397356
Biblioteca responsável:
WPRO
ABSTRACT
The effect of rosiglitazone and advanced glycation end products (AGEs) on the expression of fractalkine in cultured human renal mesangial cells (HRMC) were investigated. Rosiglitazone inhibits the upregulation of fractalkine induced by AGEs in HRMC.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Endocrinology and Metabolism
Ano de publicação:
2008
Tipo de documento:
Article